Skip to Content
Merck

103773

Benzonase® Safety Plus Emprove® Expert

buffered aqueous glycerol solution


Sign In to View Organizational & Contract Pricing

Select a Size

Pricing and availability is not currently available.

About This Item

UNSPSC Code:
12352204

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

Serratia marcescens

Quality Level

recombinant

expressed in E. coli

sterility

non-sterile

product line

EMPROVE® EXPERT

Assay

≥99% (SDS-PAGE)

form

buffered aqueous glycerol solution

feature

autoclavable: no

concentration

≥250 units/μL

impurities

≤0.25 EU/kU bacterial endotoxins

application(s)

pharma/biopharma processes

shipped in

dry ice

storage temp.

-10 to -25°C

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
7074670664E8263
assay

≥99% (SDS-PAGE)

assay

>90% (SDS-PAGE)

assay

>99% (SDS-PAGE)

assay

≥99% (SDS-PAGE)

shipped in

dry ice

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

biological source

Serratia marcescens

biological source

Serratia marcescens

biological source

Serratia marcescens

biological source

Serratia marcescens

form

buffered aqueous glycerol solution

form

buffered aqueous glycerol solution

form

buffered aqueous glycerol solution

form

buffered aqueous glycerol solution

concentration

≥250 units/μL

concentration

25-29 units/μL

concentration

25-29 units/μL

concentration

≥250 units/μL

application(s)

pharma/biopharma processes

application(s)

research use

application(s)

research use

application(s)

research use

General description

Benzonase® Nuclease is a genetically engineered endonuclease from Serratia marcescens. It degrades all forms of DNA and RNA (single stranded, double stranded, linear and circular) while having no proteolytic activity. It is effective over a wide range of conditions and possesses an exceptionally high specific activity. The enzyme completely digests nucleic acids to 5′-monophosphate terminated oligonucleotides (below the hybridization limit), which is ideal for removal of nucleic acids from recombinant proteins, enabling compliance with FDA guidelines for nucleic acid contamination. The ability of Benzonase to rapidly hydrolyze nucleic acids makes the enzyme an excellent choice for viscosity reduction to reduce processing time and increase yields of protein.

The enzyme consists of two subunits of 30 kDa each. It is functional between pH 6 and 10 and from 0-42°C and requires 1-2 mM Mg2+ for activation. The enzyme is also active in the presence of ionic and non-ionic detergents, reducing agents, PMSF (1 mM), EDTA (1 mM) and urea (relative activity depends on specific conditions). Activity is inhibited by <150 mM monovalent cations, <100 mM phosphate, <100 mM ammonium sulfate, or <100 mM guanidine HCl.
Benzonase® endonuclease Safety Plus Emprove® Expert is a companion product to our existing Benzonase® portfolio. All Benzonase® endonuclease products share the same amino acid sequence (proven by LC-MS/MS mass spectrometry), robustness and activity. Acting as endonuclease, degrading both DNA and RNA to small 3–5 base pairs (<6 kDa) fragments with no base preference, they are the ideal tool for nucleic acid removal in virus vector and vaccine manufacturing as demanded by the regulators. The use of Benzonase® endonuclease additionally increases the yield in virus purification, protects the downstream chromatography and filter devices from fouling and reduces feed stream viscosity. With its new features, Benzonase® endonuclease Safety Plus Emprove® Expert is ideally suited for manufacturing of cell and gene therapy agents such as adeno associated and lenti viruses, oncolytic viruses and viral vector vaccines.
Our SAFC® portfolio of high-quality products for biopharmaceutical processing withstands strict quality control procedures and is produced according to MQ-500 requirements as defined by the M-Clarity program.

M-Clarity Program

As part of our EMPROVE® Program, our raw materials are offered with EMPROVE® Dossiers which provide comprehensive, up-to-date documentation to help you navigate regulatory challenges, manage risks, and improve your manufacturing processes.

Our comprehensive portfolio of downstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for production of classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. Ranging from non-GMP grades for low-risk application, to IPEC-PQG GMP for higher-risk applications, we have products covering all your manufacturing needs.

Application

DNA clearance for purification of biopharmaceuticals, viral vaccines, viral vector vaccines, viral vectros for cell and gene therapy applications as well as oncolytic viruses.

Packaging

  • 100,000 Units
  • 500,000 Units
  • 5,000,000 Units + 50,000 Units tailgate sample

Preparation Note

Benzonase® endonuclease Safety Plus Emprove® Expert is manufactured under good manufacturing practices (GMP ICH Q7)

Legal Information

Benzonase is a registered trademark of Merck KGaA, Darmstadt, Germany
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

WGK

WGK 1


Stay compliant with GMP using the Emprove® Program

Accelerate qualification, maintain compliance, and save time with Emprove® Dossiers.

Download Dossiers

Note: you will be brought to EmproveSuite.com. Your username and password are separate from SigmaAldrich.com and may differ.

Register for free and access Emprove® Dossiers within minutes. Upgrade your subscription plan to unlock advanced and customized content in the Emprove® Suite

Not finding what you are looking for? Visit the Emprove® Program Help page.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

本頁說明了細胞裂解的主要注意事項,以及在 AAV 媒體製造過程中,如何結合高鹽濃度和耐鹽內切酶來提高載體滴度和感染性。

Benzonase® 內切酶能有效去除病毒生產中的核酸雜質,對細胞和基因療法及疫苗至關重要。

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

定制設計的成本模型用於探索包括 mRNA 在內的幾種不同模式的疫苗製造的經濟性。該模型可加深對製程的瞭解,模擬瓶頸,並有助於優化生產效率。

See All

Related Content

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service